PAPER Liu XJ, Yang W, Qi JS
SEARCH RESULTS
331254 RESULTS
PAPER Adachi M, Kawakatsu S, Sato T, Ohshima F
Correlation between volume and morphological changes in the hippocampal formation in Alzheimer's disease: rounding of the outline of the hippocampal body on coronal MR images.
Neuroradiology. 2012 Feb 16; PubMed: 22349566PAPER Perrin M, Henaff MA, Padovan C, Faillenot I, Merville A, Krolak-Salmon P
Influence of emotional content and context on memory in mild Alzheimer's disease.
J Alzheimers Dis. 2012 Jan 1;29(4):817-26. PubMed: 22349683PAPER Serot JM, Zmudka J, Jouanny P
A Possible Role for CSF Turnover and Choroid Plexus in the Pathogenesis of Late Onset Alzheimer's Disease.
J Alzheimers Dis. 2012 Jan 1;30(1):17-26. PubMed: 22349684PAPER Beyer N, Coulson DT, Heggarty S, Ravid R, Hellemans J, Irvine GB, Johnston JA
Zinc transporter mRNA levels in Alzheimer's disease postmortem brain.
J Alzheimers Dis. 2012 Jan 1;29(4):863-73. PubMed: 22349685PAPER Shea TB, Rogers E, Remington R
Nutrition and Dementia: Are we Asking the Right Questions?
J Alzheimers Dis. 2012 Jan 1;30(1):27-33. PubMed: 22349687PAPER
Upcoming meetings related to Alzheimer's disease.
Behav Brain Res. 2012 Mar 14; PubMed: 22349740PAPER Marra C, Gainotti G, Scaricamazza E, Piccininni C, Ferraccioli M, Quaranta D
The Multiple Features Target Cancellation (MFTC): an attentional visual conjunction search test. Normative values for the Italian population.
Neurol Sci. 2012 Feb 19; PubMed: 22350217PAPER Wang LC, Wang SE, Wang JJ, Tsai TY, Lin CH, Pan TM, Lee CL
In vitro and in vivo comparisons of the effects of the fruiting body and mycelium of Antrodia camphorata against amyloid β-protein-induced neurotoxicity and memory impairment.
Appl Microbiol Biotechnol. 2012 Feb 21; PubMed: 22350319PAPER Levy K, Lanctôt KL, Farber SB, Li A, Herrmann N
Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?
Drugs Aging. 2012 Mar 1;29(3):167-79. PubMed: 22350526PAPER Rosén C, Andreasson U, Mattsson N, Marcusson J, Minthon L, Andreasen N, Blennow K, Zetterberg H
Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.
Neuromolecular Med. 2012 Mar;14(1):65-73. Epub 2012 Feb 18 PubMed: 22350541PAPER Auburger G, Klinkenberg M, Drost J, Marcus K, Morales-Gordo B, Kunz WS, Brandt U, Broccoli V, Reichmann H, Gispert S, Jendrach M
Primary Skin Fibroblasts as a Model of Parkinson's Disease.
Mol Neurobiol. 2012 Feb 19; PubMed: 22350618PAPER Marcello E, Epis R, Saraceno C, Di Luca M
Synaptic dysfunction in Alzheimer's disease.
Adv Exp Med Biol. 2012;970:573-601. PubMed: 22351073PAPER Löffler T, Flunkert S, Taub N, Schofield EL, Ward MA, Windisch M, Hutter-Paier B
Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates.
J Mol Neurosci. 2012 May;47(1):192-203. PubMed: 22351109PAPER Keenan BT, Shulman JM, Chibnik LB, Raj T, Tran D, Sabuncu MR, , Allen AN, Corneveaux JJ, Hardy JA, Huentelman MJ, Lemere CA, Myers AJ, Nicholson-Weller A, Reiman EM, Evans DA, Bennett DA, De Jager PL
A coding variant in CR1 interacts with APOE-{varepsilon}4 to influence cognitive decline.
Hum Mol Genet. 2012 May 15;21(10):2377-2388. PubMed: 22343410Current Filters
No filters selected